NCT00226967View on ClinicalTrials.gov

Stress, Diurnal Cortisol, and Breast Cancer Survival

CompletedOBSERVATIONAL
Enrollment

115

Participants

Timeline

Start Date

September 8, 2002

Primary Completion Date

November 30, 2004

Study Completion Date

December 31, 2005

Conditions
Breast Cancer
Interventions
DRUG

Sandostatin

Calculated per patient

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Stanford University

OTHER

NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival | Biotech Hunter | Biotech Hunter